| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2021)
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
The interplay between HPCAL4 and MeCP2: identification and characterization of a novel putative target for Rett syndrome therapy
|
|
Ongoing | 2022 |
| MIS - Bandi Ministero Salute |
Enhancement of the current hematopoietic stem cell-based gene therapy to broaden its accessibility to symptomatic patients affected by Metachromatic Leukodystrophy
|
|
Ongoing | 2021 |
| PRIN2020 - PRIN bando 2020 |
Multimodal Innovative THeranostic nanoSystem
|
|
Ongoing | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
The natural antisense lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (3° anno)
|
|
Ongoing | 2023 |
| PRIN2020 - PRIN bando 2020 |
Breast implants safety: is our knowledge enough?
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
The link between metabolism and epigenetics in myocardial diseases
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
